METASTATIC MICROSATELLITE STABLE COLORECTAL CARCINOMA
Clinical trials for METASTATIC MICROSATELLITE STABLE COLORECTAL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new METASTATIC MICROSATELLITE STABLE COLORECTAL CARCINOMA trials appear
Sign up with your email to follow new studies for METASTATIC MICROSATELLITE STABLE COLORECTAL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug cocktail shows promise for Tough-to-Treat colon cancer
Disease control OngoingThis study tests whether combining two drugs—niraparib and panitumumab—can help control advanced colorectal cancer that has spread. The trial includes 26 adults whose cancer did not respond to prior treatment. The goal is to see if the combination shrinks tumors or keeps them sta…
Matched conditions: METASTATIC MICROSATELLITE STABLE COLORECTAL CARCINOMA
Phase: PHASE2 • Sponsor: Emory University • Aim: Disease control
Last updated May 26, 2026 10:27 UTC
-
Triple-Drug cocktail shows promise for Tough-to-Treat colorectal cancer
Disease control OngoingThis study tests a combination of two targeted drugs (encorafenib and cetuximab) plus an immunotherapy drug (nivolumab) in people with advanced colorectal cancer that has a specific BRAF gene change and has not responded to standard treatments. The goal is to see if this triple t…
Matched conditions: METASTATIC MICROSATELLITE STABLE COLORECTAL CARCINOMA
Phase: PHASE1, PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 22, 2026 13:52 UTC
-
New combo therapy offers hope for hard-to-treat colorectal cancer
Disease control OngoingThis early-stage trial tests a combination of chemotherapy (FOLFOX), a blood vessel blocker (bevacizumab), and two immunotherapy drugs (botensilimab and balstilimab) in 20 people with a type of advanced colorectal cancer (MSS) that has spread. The goal is to find the safest dose …
Matched conditions: METASTATIC MICROSATELLITE STABLE COLORECTAL CARCINOMA
Phase: PHASE1, PHASE2 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated May 20, 2026 11:54 UTC
-
New cocktail aims to outsmart Chemo-Resistant colorectal cancer
Disease control OngoingThis study tests a combination of three drugs (botensilimab, balstilimab, and regorafenib) in people with a type of colorectal cancer that has spread and stopped responding to chemotherapy. The goal is to see if this mix can shrink tumors or slow the disease. About 28 adults with…
Matched conditions: METASTATIC MICROSATELLITE STABLE COLORECTAL CARCINOMA
Phase: PHASE1, PHASE2 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated May 19, 2026 11:59 UTC